These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 28319337)

  • 1. Impact of mild to severe hemophilia on education and work by US men, women, and caregivers of children with hemophilia B: The Bridging Hemophilia B Experiences, Results and Opportunities into Solutions (B-HERO-S) study.
    Cutter S; Molter D; Dunn S; Hunter S; Peltier S; Haugstad K; Frick N; Holot N; Cooper DL
    Eur J Haematol; 2017 Apr; 98 Suppl 86():18-24. PubMed ID: 28319337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of mild to severe hemophilia on engagement in recreational activities by US men, women, and children with hemophilia B: The Bridging Hemophilia B Experiences, Results and Opportunities into Solutions (B-HERO-S) study.
    Baumann K; Hernandez G; Witkop M; Peltier S; Dunn S; Cutter S; Frick N; Haugstad K; Guelcher C; Frey MJ; Rotellini D; Clark DB; Iyer NN; Cooper DL
    Eur J Haematol; 2017 Apr; 98 Suppl 86():25-34. PubMed ID: 28319336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of US men, women, and children with hemophilia and methods and demographics of the Bridging Hemophilia B Experiences, Results and Opportunities into Solutions (B-HERO-S) study.
    Buckner TW; Witkop M; Guelcher C; Frey MJ; Hunter S; Peltier S; Recht M; Walsh C; Kessler CM; Owens W; Clark DB; Frick N; Rice M; Iyer NN; Holot N; Cooper DL; Sidonio R
    Eur J Haematol; 2017 Apr; 98 Suppl 86():5-17. PubMed ID: 28319338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the psychosocial impact of hemophilia B: The Bridging Hemophilia B Experiences, Results and Opportunities into Solutions (B-HERO-S) study.
    Sidonio R; Holot N; Cooper DL
    Eur J Haematol; 2017 Apr; 98 Suppl 86():3-4. PubMed ID: 28319335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of hemophilia B on quality of life in affected men, women, and caregivers-Assessment of patient-reported outcomes in the B-HERO-S study.
    Buckner TW; Witkop M; Guelcher C; Sidonio R; Kessler CM; Clark DB; Owens W; Frick N; Iyer NN; Cooper DL
    Eur J Haematol; 2018 Jun; 100(6):592-602. PubMed ID: 29505680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reliability and validity of patient-reported outcome instruments in US adults with hemophilia B and caregivers in the B-HERO-S study.
    Buckner TW; Sidonio R; Guelcher C; Kessler CM; Witkop M; Clark D; Owens W; Fridman M; Iyer NN; Cooper DL
    Eur J Haematol; 2018 Dec; 101(6):781-790. PubMed ID: 30179272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mild-severe hemophilia B impacts relationships of US adults and children with hemophilia B and their families: results from the B-HERO-S study.
    Cutter S; Guelcher C; Hunter S; Rotellini D; Dunn S; Cooper DL
    Patient Relat Outcome Meas; 2019; 10():257-266. PubMed ID: 31496854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BE EMPOWERED, a specialty pharmacy education program for hemophilia B patients, impacts adult joint bleeds and pediatric use of RICE.
    Blankenship CS; Tortella BJ; Bruno M
    J Manag Care Pharm; 2014 Feb; 20(2):151-8. PubMed ID: 24456316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlations between patient-reported outcomes and self-reported characteristics in adults with hemophilia B and caregivers of children with hemophilia B: analysis of the B-HERO-S study.
    Buckner TW; Sidonio R; Witkop M; Guelcher C; Cutter S; Iyer NN; Cooper DL
    Patient Relat Outcome Meas; 2019; 10():299-314. PubMed ID: 31572035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of haemophilia on patients with mild-to-moderate disease: Results from the P-FiQ and B-HERO-S studies.
    Witkop M; Wang M; Hernandez G; Recht M; Baumann K; Cooper DL
    Haemophilia; 2021 Jan; 27 Suppl 1():8-16. PubMed ID: 33522654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment outcomes, quality of life, and impact of hemophilia on young adults (aged 18-30 years) with hemophilia.
    Witkop M; Guelcher C; Forsyth A; Hawk S; Curtis R; Kelley L; Frick N; Rice M; Rosu G; Cooper DL
    Am J Hematol; 2015 Dec; 90 Suppl 2():S3-10. PubMed ID: 26619194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemophilia Experiences, Results and Opportunities (HERO) Study: survey methodology and population demographics.
    Forsyth AL; Gregory M; Nugent D; Garrido C; Pilgaard T; Cooper DL; Iorio A
    Haemophilia; 2014 Jan; 20(1):44-51. PubMed ID: 23902228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic Burden of Illness among Persons with Hemophilia B from HUGS Vb: Examining the Association of Severity and Treatment Regimens with Costs and Annual Bleed Rates.
    Chen CX; Baker JR; Nichol MB
    Value Health; 2017 Sep; 20(8):1074-1082. PubMed ID: 28964439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemophilia Experiences, Results and Opportunities (HERO study) in Brazil: Assessment of the psychosocial effects of haemophilia in patients and caregivers.
    Lorenzato CS; Santos RB; Fagundes GZZ; Ozelo MC
    Haemophilia; 2019 Jul; 25(4):640-650. PubMed ID: 31115094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of acute bleeding on daily activities of patients with congenital hemophilia with inhibitors and their caregivers and families: observations from the Dosing Observational Study in Hemophilia (DOSE).
    Recht M; Neufeld EJ; Sharma VR; Solem CT; Pickard AS; Gut RZ; Cooper DL
    Value Health; 2014 Sep; 17(6):744-8. PubMed ID: 25236999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemophilia and sexual health: results from the HERO and B-HERO-S studies.
    Blamey G; Buranahirun C; Buzzi A; Cooper DL; Cutter S; Geraghty S; Saad H; Yang R
    Patient Relat Outcome Meas; 2019; 10():243-255. PubMed ID: 31616195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unmet needs in the transition to adulthood: 18- to 30-year-old people with hemophilia.
    Quon D; Reding M; Guelcher C; Peltier S; Witkop M; Cutter S; Buranahirun C; Molter D; Frey MJ; Forsyth A; Tran DB; Curtis R; Hiura G; Levesque J; de la Riva D; Compton M; Iyer NN; Holot N; Cooper DL
    Am J Hematol; 2015 Dec; 90 Suppl 2():S17-22. PubMed ID: 26619193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of an individualized prophylaxis approach on young adults with severe hemophilia.
    Fernandes S; Carvalho M; Lopes M; Araújo F
    Semin Thromb Hemost; 2014 Oct; 40(7):785-9. PubMed ID: 25313523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of haemophilia with inhibitors on caregiver burden in the United States.
    DeKoven M; Karkare S; Lee WC; Kelley LA; Cooper DL; Pham H; Powers J; Wisniewski T
    Haemophilia; 2014 Nov; 20(6):822-30. PubMed ID: 25273645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of acute bleeding on daily quality of life assessments in patients with congenital hemophilia with inhibitors and their families: observations from the dosing observational study in hemophilia.
    Neufeld EJ; Recht M; Sabio H; Saxena K; Solem CT; Pickard AS; Gut RZ; Cooper DL
    Value Health; 2012; 15(6):916-25. PubMed ID: 22999142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.